AN2 Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
an2-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | BML Capital Management, LLC(2025-03-31) | $7.8M |
2 | Almitas Capital LLC(2025-03-31) | $1.8M |
3 | VANGUARD GROUP INC(2025-03-31) | $1.4M |
4 | ADAGE CAPITAL PARTNERS GP, L.L.C.(2025-03-31) | $1.4M |
5 | PFIZER INC(2025-03-31) | $972.8K |
6 | Peapod Lane Capital LLC(2025-03-31) | $790.0K |
7 | BANK OF NOVA SCOTIA(2025-03-31) | $624.5K |
8 | TWO SIGMA ADVISERS, LP(2025-03-31) | $605.2K |
9 | BANK OF MONTREAL /CAN/(2025-03-31) | $574.0K |
10 | Aldebaran Capital, LLC(2025-03-31) | $553.0K |
11 | BANK OF AMERICA CORP /DE/(2025-03-31) | $524.3K |
12 | RENAISSANCE TECHNOLOGIES LLC(2025-03-31) | $501.4K |
13 | TWO SIGMA INVESTMENTS, LP(2025-03-31) | $467.8K |
14 | BlackRock, Inc.(2025-03-31) | $408.9K |
15 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $345.4K |
16 | Stonepine Capital Management, LLC(2024-12-31) | $271.5K |
17 | UBS Group AG(2025-03-31) | $144.2K |
18 | STATE STREET CORP(2025-03-31) | $118.3K |
19 | Marquette Asset Management, LLC(2024-12-31) | $114.8K |
20 | CITADEL ADVISORS LLC(2024-12-31) | $93.8K |
As of 2025-03-31
Value:$7.8M
As of 2025-03-31
Value:$1.8M
As of 2025-03-31
Value:$1.4M
As of 2025-03-31
Value:$1.4M
As of 2025-03-31
Value:$972.8K
As of 2025-03-31
Value:$790.0K
As of 2025-03-31
Value:$624.5K
As of 2025-03-31
Value:$605.2K
As of 2025-03-31
Value:$574.0K
As of 2025-03-31
Value:$553.0K
As of 2025-03-31
Value:$524.3K
As of 2025-03-31
Value:$501.4K
As of 2025-03-31
Value:$467.8K
As of 2025-03-31
Value:$408.9K
As of 2025-03-31
Value:$345.4K
As of 2024-12-31
Value:$271.5K
#17UBS Group AG
As of 2025-03-31
Value:$144.2K
As of 2025-03-31
Value:$118.3K
As of 2024-12-31
Value:$114.8K
As of 2024-12-31
Value:$93.8K
Total Institutional Holders:44
Top 10 Holders Own:82.0%